1. Kailash C Bhol received his Ph.D. degree in Immunology/Parasitology from University of Kalyani, India. Then worked as Research Scientist in Organon Research Center, India. As a postdoctoral research fellow and Faculty at Harvard School of Dental Medicine, he studied molecular mechanisms and new therapies for autoimmune blistering diseases. Then he moved to Pharmaceutical industries and worked for five Pharmaceutical Companies and couple of Contract Research Organizations. Dr. Bhol has more than 18 years of experience in leading Preclinical Development of biological derived products including Proteins, antibodies, cell therapy, and gene therapy and small molecules for different indications including oncology and inflammatory/autoimmune diseases, metabolic diseases and neurological, ophthalmological diseases and other indications. He has successfully moved many products to the clinics. Dr. Bhol has published 57 papers and presented his works at different national and international meetings.